HRP20070084T3 - ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS - Google Patents

ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS

Info

Publication number
HRP20070084T3
HRP20070084T3 HR20070084T HRP20070084T HRP20070084T3 HR P20070084 T3 HRP20070084 T3 HR P20070084T3 HR 20070084 T HR20070084 T HR 20070084T HR P20070084 T HRP20070084 T HR P20070084T HR P20070084 T3 HRP20070084 T3 HR P20070084T3
Authority
HR
Croatia
Prior art keywords
acapsular
multocida
deletion mutants
hyae
birds
Prior art date
Application number
HR20070084T
Other languages
English (en)
Croatian (hr)
Inventor
E. Briggs Robert
M. Tatum Fred
Original Assignee
Biotechnology Research And Development Corporation
The United States Of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research And Development Corporation, The United States Of America filed Critical Biotechnology Research And Development Corporation
Publication of HRP20070084T3 publication Critical patent/HRP20070084T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
HR20070084T 2003-07-02 2007-03-02 ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS HRP20070084T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60893103P 2003-07-02 2003-07-02
PCT/US2004/021274 WO2005003330A2 (en) 2003-07-02 2004-07-02 Acapsular p. multocida hyae deletion mutants

Publications (1)

Publication Number Publication Date
HRP20070084T3 true HRP20070084T3 (en) 2008-09-30

Family

ID=33564219

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070084T HRP20070084T3 (en) 2003-07-02 2007-03-02 ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS

Country Status (20)

Country Link
US (1) US7351416B2 (xx)
EP (1) EP1638598B1 (xx)
JP (2) JP5001647B2 (xx)
KR (1) KR101119216B1 (xx)
CN (1) CN1798574B (xx)
AT (1) ATE347373T1 (xx)
AU (1) AU2004254619B2 (xx)
BR (1) BRPI0410911B1 (xx)
CA (1) CA2530779C (xx)
DE (1) DE602004003582T2 (xx)
DK (1) DK1638598T3 (xx)
ES (1) ES2278344T3 (xx)
HK (1) HK1088561A1 (xx)
HR (1) HRP20070084T3 (xx)
NZ (1) NZ543771A (xx)
PL (1) PL1638598T3 (xx)
PT (1) PT1638598E (xx)
SI (1) SI1638598T1 (xx)
WO (1) WO2005003330A2 (xx)
ZA (1) ZA200509533B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080241192A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
JP5808671B2 (ja) * 2008-11-10 2015-11-10 ノヴォ ノルディスク アー/エス 機能グループii莢膜遺伝子クラスターを有しないe.colibl21株
US9115547B2 (en) * 2009-06-22 2015-08-25 Frank's International, Llc Large diameter tubular lifting apparatuses and methods
WO2010149190A1 (en) 2009-06-26 2010-12-29 Max-Planck-Gesellschaft Zur Novel fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
EP3384927B1 (en) 2012-11-08 2022-07-06 Boehringer Ingelheim Animal Health USA Inc. Attenuated manheimia haemolytica vaccines and methods of making and use
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
EP3188750B1 (en) 2014-09-03 2020-03-11 Intervet International B.V. Attenuated bovine coronavirus and related vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
US20010018055A1 (en) * 1997-09-25 2001-08-30 Briggs Robert E. Deletion mutants of virulence factors of pasteurellaceae
IL158007A0 (en) * 2001-03-23 2004-03-28 S2 Technologies Inc Development and testing system and method
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
ES2346915T3 (es) * 2002-04-05 2010-10-21 Merial Bacterias gram negativas atenuadas.

Also Published As

Publication number Publication date
DK1638598T3 (da) 2007-03-26
KR101119216B1 (ko) 2013-03-18
ATE347373T1 (de) 2006-12-15
US7351416B2 (en) 2008-04-01
JP2011024587A (ja) 2011-02-10
HK1088561A1 (en) 2006-12-08
CA2530779A1 (en) 2005-01-13
CA2530779C (en) 2012-06-05
CN1798574B (zh) 2013-12-11
DE602004003582T2 (de) 2007-09-20
US20050106185A1 (en) 2005-05-19
KR20060020657A (ko) 2006-03-06
BRPI0410911A (pt) 2006-06-27
DE602004003582D1 (de) 2007-01-18
WO2005003330A3 (en) 2005-03-03
AU2004254619B2 (en) 2009-05-21
AU2004254619A1 (en) 2005-01-13
PL1638598T3 (pl) 2007-05-31
WO2005003330A2 (en) 2005-01-13
ES2278344T3 (es) 2007-08-01
NZ543771A (en) 2008-05-30
SI1638598T1 (sl) 2007-04-30
PT1638598E (pt) 2007-03-30
JP5649881B2 (ja) 2015-01-07
JP5001647B2 (ja) 2012-08-15
EP1638598A2 (en) 2006-03-29
BRPI0410911B1 (pt) 2014-07-08
CN1798574A (zh) 2006-07-05
JP2007524398A (ja) 2007-08-30
EP1638598B1 (en) 2006-12-06
ZA200509533B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
HK1088561A1 (en) Acapsular i p. multocida hyae /I. deletion mutants
O'Brien et al. IL‐17‐producing γδ T cells
NO971051D0 (no) Middel for å öke produksjonen av oppdretts- og produksjonsdyr i fjærfeindustrien
AR076613A1 (es) Alimento para mascotas en forma de alimento granulado recubierto
BRPI0510930A (pt) vacinas de subunidade de prrsv
Murphy et al. Pig‐shed air polluted by α‐haemolytic cocci and ammonia causes subclinical disease and production losses
NO20040354L (no) Fremgangsmater og sammensetninger for kontroll av koksidose
WO2003096799A3 (en) Multiple closed nucleus breeding for swine production
FI20021518A0 (fi) Avidiinin lämpökestävyyden lisääminen
RU2009101018A (ru) Индукция толерантности к белкам яиц
ATE377943T1 (de) Verfahren zur züchtung von nicht-menschliche säugertieren
MXPA03004032A (es) Agente alimenticio.
TW200502295A (en) Polyamide and polyvinylbutyral compositions and blends comprising mineral filler and articles made therefrom
Ji et al. Mechanism of mariculture self-pollution and its effects on environment.
MD891G2 (ro) Metodă de stimulare a sistemului imun al animalelor
SE9800505L (sv) Probiotisk komposition innehållande sporer från jästarten Endomyces fibuliger och användning därav
MXPA05009489A (es) Procedimientos para identificacion de atributos geneticos en animales.
CN209151908U (zh) 一种福利化猪隔离装置
ATE419393T1 (de) Polymorphismus des igf2-gens und verbesserte produktionseigenschaften von rindern
BR9910227A (pt) Métodos de criação de animais para a produção de carne.
Liorancas et al. Influence of rearing space on the behavior, performance, carcass and meat quality of pigs
CN204426256U (zh) 可便于排泄物回收的圈养结构
CN107347676A (zh) 一种创新型木质狗窝
White Economic impact of value based marketing of fed cattle on the beef cow-calf retained ownership decision
Bell Sustainable fishmeal